FibroGen (FGEN) Tops Q2 EPS by 10c

FibroGen (NASDAQ: FGEN) reported Q2 EPS of $0.83, $0.10 better than the analyst estimate of $0.73. Revenue for the quarter came in at $120.55 million versus the consensus estimate of $111.75 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
• Newmarket (NEU) Reports Q1 EPS of $11.23
• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance